Course status - Staffcentral - University of Brighton

chatteryellvilleΒιοτεχνολογία

20 Φεβ 2013 (πριν από 4 χρόνια και 10 μήνες)

200 εμφανίσεις


UNIVERSITY OF BRIGHTON


PROGRAMME SPECIFICATION


PART 1: COURSE SUMMARY INFORMATION
1

Awarding body

University of Brighton

School

Pharmacy and Biomolecular Sciences

Faculty

Science and Engineering

Partner institution(s)



Course status

Validation/Franchise/Joint
2

Host
Department


Location of
Study/campus

Moulsecoomb

Professional,
Statutory and
Regulatory Body

General Pharmaceutical Council

Award and titles

Award

Title

Final award

MPharm (Hons)

Master of Pharmacy with Honours

Intermediate award

Cert HE
(Science)

Certificate of Higher Education
in Science

Intermediate award

Dip HE
(Science)

Diploma of Higher Education in
Science

Intermediate award

BSc

Bachelor of Science in
Pharmaceutical Studies

Intermediate award

BSc (Hons
)

Bachelor of Science in
Pharmaceutical Studies with
Honours

Mode of study

Duration of
study
(standard)

Maximum registration period

Full
-
time

4 years

6 years

Sandwich

5 years

7 years

Part Time



Distance



Start date for
programme
(month/session)

Septem
ber 2010 (year
4 only
, no new students to
this programme)
)

Course codes/categories

UCAS code

B230

QAA Subject Benchmark

Pharmacy

CATS points for
course

480

Admissions Agency

UCAS

Yes

GTTR


NMAS


Direct to School






1

Information from Part 1 is entered onto the courses database

2

Delete/cross through as appropriate


Admissions criteria

The
normal minimum entrance requirements to the course are:


A pass in English Language at GCSE or GCE (Grade C or above) or CSE
(Grade 1)


or
a pass in one of the following:


(i)

the JMB test in English,

(ii)

the TOEFL test (575

points in written test

or 232 in computer test or 91 in internet
-
based test
),

(iii)

the IELTS test (a score of 6
.5

or equivalent with a score of at least 6 in the written test),

(iv)

the International Baccalaureate.


Qualifications in English Language equivalent to the above wi
ll be considered.


plus


Passes in three subjects at GCE Advanced Level (either A2 or A2/AS combination) which must include
chemistry and two more from the following:


(i)

a biological science,

(ii)

a mathematical science,

(iii)

physics,

(iv)

an
appropriate alternative science.


The preferred option is chemistry, biology and mathematics.


Normally
the minimum requirement at Advanced level (eithe
r A2 or A2/AS
combination) is 320 points with at least 10
0 points in chemistry. A
pass
in biology at GC
SE
will be required if not offered at Advanced
level.


or


Pass
with triple distinction in BTEC Diploma.


or


Pass in an approved Access course usually at a level equivalent to 70% in the final year of the course.
Particular attention is paid to the
chemistry component of the course and the level of achievement in this
component.


or


Pass in the International Ba
ccalaureate with a minimum of 32

points, including chemistry
and biology
at
Higher level, usually at Grade 5

or above.

Contacts

Course Lead
er (or
Course Development
Leader)

Dr
G Olivier

Admissions Tutor

n/a


Examination and Assessment

External Examiner(s)

Dr J S McLay,

Dr S Murdan, Professor L Goodyer

Examination Board(s)
(AEB/CEB)

AEBs: Pharmacology and Therape
ut
ics, Chemical
and
Pharmaceutical Sciences, Biology and
Biomedical Sciences

CEB:
MPharm (Stages 3 and 4), BSc (Ho
ns)
Pharmacol
ogical S
ciences and PGDip Pharmacy
(OSPAP).


Approval/start dates

Start date
(month/session)

September 2010

(
year
4 only)


Approval date

Review
date

Validation

July 2003

n/a (course running out)

Programme
Specification

July

20
10

n/a


PART 2: COURSE DETAILS


AIMS AND LEARNING OUTCOMES

Aims:

The aims of the programme are:




To encourage the development of critical thinking,
integrative capabilities and problem
-
solving skills
appropriate for a Master’s degree.



To facilitate the development of personal, social,
behavioural and communication skills for effective
interaction wit
h patients, colleagues and health care
professionals.



To provide students with an academic and scientific
education and the skills which enables them to
successfully undertake the pre
-
registration year and
subsequently pursue a career in any branch of
phar
macy.



To engender professional and ethical awareness and an
appreciation of the benefits of continuing
professional development.


Learning
outcomes

By the end of the course the MPharm graduate will have
demonst
r
ated:



Knowledge



an appreciation of
research methods used in natural,
clinical and social sciences.



critical thinking, interpretive and problem
-
solving
capabilities, sometimes in the absence of complete
data.



an understanding of and ability to explain the
scientific principles underlying the

design,
production, mechanisms of action and use of drugs and
medicines.



an appreciation of the principles of quality and
quality assurance mechanisms in appropriate aspects
of scientific and professional activities.




an understand of the rôle of pharmacy
in primary
health care.



an ability to discuss the social and ethical issues
arising from the practice of pharmacy.



sufficient academic and professional knowledge to
interpret and evaluate prescriptions and other
relevant and appropriate orders for drugs
and
medicines.



the capability to appraise critically a patient’s
medication and formulate a Pharmaceutical Care Plan,
suggesting, where necessary, alterations in dosage
form / strength or therapy.



a knowledge of adverse drug reactions and medication
errors

and the appropriate systems for their
prevention, monitoring and reporting.



the recognition of modifiable risk factors for health
and appropriate means of client education and the
promotion of healthy lifestyles.



an appreciation of the place of complement
ary and
alternative therapies in modern healthcare.

Skills



a capability to use information technology
effectively to gather, integrate and communicate
information relevant to pharmacy.



an ability to take responsibility for, and
successfully undertake, an o
n
-
going, reflective
learning programme with the ability to adapt to
changing requirements and expectations.



competence in performing pharmaceutical calculations.



ability to supply drugs and medicines in accordance
with current legislation and codes of prof
essional
conduct and practice.



ability to dispense medicines extemporaneously.



the capability to elicit appropriate information from
clients and the recognition of the symptoms of common
diseases with appropriate counse
l
ling and advice on
the correct use o
f drugs and medicines, both
prescribed and non
-
prescribed; the recognition of the
need to refer major conditions.



PROGRAMME STRUCTURE


The subject matter of the MPharm programme is broadly divided into two
themes: Pharmaceutical Sciences and Clinical
and Professional
Studies. Within the two themes individual units of study integrate
the traditional subject areas of chemistry, pharmaceutics,
microbiology, biology, physiology, pharmacology, clinical pharmacy,
pharmacy practice and medical psychology. T
he MPharm course is
presented as a small number of large units of study which, for
operational reasons, have been ascribed separate module codes defined
by the assessment task.


Level one of the course concentrates on providing the essential

underpinning i
n chemistry, biology and maths whilst introducing
students to the new concepts of pharmacology and pharmacy practice,
using common, well
-
known diseases as exemplars.


Levels two and three present the sciences underlying the production
and use of medicines
and the professional roles of the pharmacist.


The final year is dominated by the research project and in
-
depth
consideration of specialized subject areas including business studies
and law and ethics.


Graduates of the MPharm programme are eligible for
registration with
and membership of the Royal Pharmaceutical Society of Great Britain
only after successful completion of a one
-
year period of Pre
-
Registration Training and a Pre
-
Registration Examination. Students on
the Brighton MPharm programme may opt
to undertake part of their Pre
-
Registration Training prior to graduation either by undertaking a 6
-
month training period after completion of level 3 and prior to re
-
joining the fourth year at the beginning of semester 2 or by
undertaking 12 months of pre
-
R
egistration training following
completion of the first semester of the fourth year prior to rejoining
second semester, year 4, 12 months later.


The mandatory and compulsory modules on the course are shown below.


Module codes

Statu
s*

Module Title

Credit

Level
4




CH111

C

Introduction to chemical and molecular
sciences

10

CH112

C

Fundamental chemical and molecular
sciences

10

BY130

C

Essential cell biology and biochemistry

20

PY134

C

Basic pharmacology

10

QS117

C

Quantitative skills

10

PY131

C

Respiratory and dermatological therapies
in pharmacy practice (Coursework)

20

PY132

C

Respiratory and dermatological therapies
in pharmacy practice (Examination)

20

CH133

C

Principles of pharmaceutical analysis

20

Level
5




CH231

C

Medicine design
and analysis (Coursework)

20

CH232

C

Medicine design and analysis (Examination)

20

PY233

C

Therapeutic aspects of neuroendocrinology
and pharmacokinetics (Coursework)

10

PY234

C

Therapeutic aspects of neuroendocrinology
and pharmacokinetics
(Examination)

20

PY235

C

Therapeutic aspects of neuroendocrinology
and pharmacokinetics (OSCE)

10

BY226

C

Pharmaceutical microbiology, immunology
and biotechnology (Coursework)

20

PY237

C

Pharmaceutical microbiology, immunology
and biotechnology
(Examination)

20

Level
6





CH331

C

Biopharmaceutics and medicinal chemistry
(Coursework)

20

CH332

C

Biopharmaceutics and medicinal chemistry
(Examination)

20

CH333

C

Microbiological and quality assurance
aspects of medicines' production

20

PY334

C

Therapeutic aspects of cardiovascular
pharmacy and oncology (Coursework)

10

PY335

C

Therapeutic aspects of cardiovascular
pharmacy and oncology (Examination)

20

PY336

C

Therapeutic aspects of cardiovascular
pharmacy and oncology (OSCE)

10

PY337

C

Neurological and psychiatric pharmacy

20

Level

7




PYM31/CHM31/BY
M31

M

Project

50

PYM01
-
07/

CHM01
-
05

C

Special topic modules (x 2)

10 each

CHM33

C

Advanced drug delivery

10

PYM34

M

Advanced professional studies

10

PYM35

C

Pharmaceutical skills in
multi
-
system
disorders

20

PYM36

C

Business studies for pharmacists

10

*M = Mandatory C = Compulsory O = Optional



LEARNING, TEACHING AND ASSESSMENT

Learning
and
teaching

This section should set out the primary learning and
teaching methods, including total learning hours and any
specific requirements in terms of practical/clinical
-
based
learning)


The 4
-
year course consists of 1558 student class contact
hours and 1802 hou
rs of independent guided study. The
class contact hours are comprised of the following:




846 hours of lectures (54%)



538 hours of manipulative laboratory assignments (35%)



74 hours of seminars (5%)



100 hours of experiential learning (6%)


It is a requirem
ent of the Royal Pharmaceutical Society GB
that at least 35% if the MPharm programme is comprised of
manipulative (laboratory) exercises.

Assessment

A variety of methods of assessment are used throughout the
course. These are designed to test the student's
achievements in terms of the prescribed learning outcomes
of the module concerned and, where appropriate key
transferable skills. Coursework ie mani
pulative laboratory
exercises, case studies, Objective Structured Clinical
Examinations (OSCEs), portfolios, numeracy tests, oral
presentations and interpretive exercises, together with
the associated guided study, is assessed continuously.
Such exercises
are designed to assess the student's

ability to generate, present, analyse and discuss
experimental and clinical data. In addition, such
exercises act as feedback thereby allowing the student to
determine and direct his/her learning strategies. The
theory
component of the course, principally lectures and
the associated guided study, is assessed by end
-
of
-
module
written examination. The precise format of this
examination depends on the particular module in question
and its location within the programme of st
udy. Thus some
written examinations in the early part of the course
include MCQs and short answer questions, thereby testing
factual recall, open
-
book mathematical examinations
testing problem solving and traditional essay
-

type
answer.

Later in the cours
e, traditional essay
-
type answers test
the student’s ability to reason and discuss appropriate
issues.


Students are also required to maintain a compulsory, non
-
graded, reflective log
-
book throughout the course which
must be presented to the personal tutor

each semester.


REGULATIONS

Regulations

The course regulations are in accordance with the
University's General Examination and Assessment
Regulations (available from the school office or the
Registry).


In addition, the following course
-
specific
regulations
apply.


Continuance on the course is subject to a CRB disclosure.


Pass mark for modules is 40% unless otherwise stated in the module descriptor.


Candidates must have studied all compulsory MPharm modules
and must have achieved 480 credits, of

which 120 must be
at M
-
level. With the exception of QS117, no other module
may substitute for any of the prescribed MPharm modules.


In addition candidates must have:

i)

successfully completed a non
-
graded reflective
portfolio.

ii)

passed the assessment

in Professional Competency
This assessment is comprised of a series of tests
taken under examination conditions. The first test
will take place at level one as part of PY131 and
involve dispensing a number of items including at
least one extemporaneous
dispensed item. The level 1
assessment will contribute up to a maximum of 10%
towards the overall Professional Competency
Assessment. The second test will take place at level
2 as part of the coursework of PY234 and will involve
dispensing some items and

include some basic
consultation with a simulated patient about the

dispensed medicine. The level 2 assessment will
contribute up to a maximum of 20% towards the overall
Professional Competency Assessment. The final two
assessments will take place at leve
l 3 as part of the
coursework for modules PY334 and PY337. One
assessment will involve identification and resolution
of a number of pharmaceutical problems and the
dispensing of a number of items together with the
associated consultation with a simulated
patient.
The second level 3 assessment will involve dispensing
a number of items, all of which are controlled drugs.
The level 3 assessments will contribute up to a
maximum of 35% each towards the overall Professional
Competency Assessment. Students mus
t achieve an
overall mark of at least 50% to be considered
competent at dispensing, with marks of not less than
35% in either of the level 3 assessments (60% in the
Professional Competency Assessment).



Students deemed competent at dispensing can proceed

to level 4 of the course, students failing the
Pharmacy Practice assessment will be required to
undertake supplementary assessments.


iii)

successfully completed PYM34 which contains an update
of pharmacy legislation and professional practice.


PROFESSIONAL AND STATUORY BODY DETAILS (optional)


The curriculum follows the indicative syllabus for pharmacy published
by the

General Pharmaceutical Council
, which itself is based upon the
relevant EU directive.


LEARNING SUPPORT

Central support: all
students benefit from:


University induction week

Student Handbook

Course Handbook

Extensive library facilities

Computer pool rooms (
indicate number of workstations by site
)

E
-
mail address

Welfare service

Personal tutor for advice and guidance

Course
specific: in addition, students on this course benefit from:




Student Course Handbook



Extensive StudentCentral provision



Focus Groups



Staff
-

Student Committee


ADDITIONAL INFORMATION

More detailed information about the course can be found in a range
of
documents, including



Student Handbook

Studentcentral

University Student Handbook

General Examination and Assessment Regulations for Taught Courses


Research informed teaching

Teaching in the school is informed by research of very high quality. In
the
2008 RAE 80% of the research submitted for consideration by the
School was judged to be of international quality of which 15% was
internationally leading. The course is delivered by research active
staff and many of the final year modules are focussed dire
ctly on their
research interests. For the final year project, students are placed in
research areas within the School and benefit from the research
expertise of their project supervisors. Students are expected to engage
in experimental design with several
students each year going on to join
PhD research programmes. In addition, the course has an Education
Research Unit that was established to undertake research into pedagogic
issues that arise from local and national issues. This informs the
course curricul
um design and teaching methods.


Sustainable Development
-

Technological developments arise out of
science, and problems generated by development are solved by knowledge
gained from further science. Therefore the course educates students for
sustainable de
velopment by studying science and developing scientific
skills, research skills and critical thinking. Pharmacy students,
through their studies, gain insight into the causes and treatments of
disease and graduates are equipped to make a significant input i
nto the
management of diseases. Their impact on the health of the nation with
the associated sustainability benefits, especially in the area of
preventable diseases, will be large.


QUALITY INDICATORS

This section details external indicators of the
quality of the
provision

QAA Subject Review outcome and
date

23 out of 24 (1999)


National student awards



Professional accreditation:


Royal Pharmaceutical Society of Great
Britain